Publication
Article
Pharmacy Times
Read about the new generic products featured in June.
VITAMIN D3 10,000 IU
MARKETED BY: Nnodum Pharmaceuticals
COMPARE TO: Vitamin D
INDICATION: Nnodum has introduced Vitamin D3 10,000 IU to solve dosing issues associated with vitamin D and provide supplementation. Vitamin D3 is more bioavailable than any form of vitamin D and is easy to titrate, depending on the patient’s therapeutic level.
DOSAGE FORM: 30-count soft-gel capsule bottle
FOR MORE INFORMATION: nnodumpharma.com
OXYCODONE AND ACETAMINOPHEN TABLETSMARKETED BY: Camber Pharmaceuticals
COMPARE TO: Percocet (Endo Pharmaceuticals Inc)
INDICATION: Camber has announced the launch of its Oxycodone and Acetaminophen Tablets, USP, the generic version of Percocet tablets, for the treatment of moderate to moderately severe pain.
DOSAGE FORM: Tablets: 2.5/325 mg, 5/325 mg, 7.5/325 mg, and 10/325 mg
FOR MORE INFORMATION: camberpharma.com
MOMETASONE FUROATE NASAL SPRAYMARKETED BY: Amneal Pharmaceuticals LLC
COMPARE TO: Nasonex (Merck & Co, Inc)
INDICATION: Amneal has launched Mometasone Furoate Nasal Spray, 50 mcg, an AB-rated equivalent to Nasonex. Nasonex is used to treat nasal symptoms of seasonal or yearround allergies, including congestion, sneezing, and runny nose.
DOSAGE FORM: Nasal spray: 50 mcg/spray
FOR MORE INFORMATION: amneal.com
TAZAROTENE TOPICAL CREAMCOMPARE TO: Tazorac (Allergan)
MARKETED BY: Taro Pharmaceuticals
INDICATION: Taro Pharmaceuticals launched an AB-rated generic version of Tazorac (tazarotene) 0.1% topical cream. Tazorac 0.1% is indicated for the topical treatment of patients with plaque psoriasis and acne vulgaris.
DOSAGE FORM: Cream: 0.1%
FOR MORE INFORMATION: taro.com